Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shidiaolan Formula Granule is a Traditional Chinese Medicine (TCM) product in the pipeline of Guizhou Yibai Pharmaceutical. It is a standardized, single-herb concentrated granule prepared by the extraction and granulation of the dried whole plant of *Lysionotus pauciflorus* Maxim. (family Gesneriaceae). As a modern dosage form of traditional Chinese herbs, it is designed for convenient administration while maintaining the therapeutic properties of the raw herb. Traditionally, Shidiaolan has been utilized in Chinese medicine for its anti-inflammatory effects and for treating respiratory conditions such as cough, bronchitis, and pulmonary infections. Guizhou Yibai Pharmaceutical is a designated pilot enterprise for TCM formula granule research in Guizhou Province, and provincial standards for this specific granule have been established or are under development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shidiaolan Formula Granule.